Validation of a Multiplex Hypermethylation-based Blood Test to Detect Hepatocellular Carcinoma: A Prospective Case-control Study [0.03%]
用于检测肝细胞癌的多重甲基化血液检测验证：一项前瞻性病例对照研究
Ashwin Rammohan,Dinesh Jothimani,Kunkumabalasubramanian Sreedurgalakshmi et al.
Ashwin Rammohan et al.
Background/aims: This study aimed to evaluate the performance of an investigational multiplex hypermethylation-based HCC screening test (mhsH) in the detection of hepatocellular carcinoma (HCC) using blood samples. ...
Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With "Precision" Resulting in Excellent Outcomes [0.03%]
乳腺癌的肝脏内脏危象："精准"攻击旧敌获得良好疗效
Varsha Bhandarkar,Pradnya Modak,K Muthulingeshkumar et al.
Varsha Bhandarkar et al.
Liver-related Events and Outcomes in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease Varies With the Type of Cardiometabolic Risk Factor [0.03%]
与代谢紊乱相关脂肪性肝病患者肝脏事件和结局因心血管代谢危险因素类型而异
Shekhar Swaroop,Sagnik Biswas,Shubham Mehta et al.
Shekhar Swaroop et al.
Background: The long-term impact of individual cardiometabolic risk factors (CMRFs) and their combinations on outcomes in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) remains poorly defin...
Feasibility, Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis [0.03%]
经颈静脉肝内门体分流术治疗肝硬化门静脉血栓的可行性、安全性和有效性研究
Andrés Conthe,Luis Ibañez-Samaniego,Enrique Calleja et al.
Andrés Conthe et al.
Background & aims: Anticoagulation is considered the standard of care for portal vein thrombosis (PVT) in cirrhosis; however, a significant number of patients cannot be safely treated or exhibit thrombus progression despi...
Carbapenem-resistant Enterobacteriaceae Colonization and Impact on Outcomes in Cirrhosis [0.03%]
碳青霉烯耐药肠杆菌科细菌定植与肝硬化的临床结局之间的关系
Venishetty Shantan,Kalyan Rakam,Amarthya Sree Racha et al.
Venishetty Shantan et al.
Challenges and Future Perspectives for Artificial Intelligence in Hepatology: Breaking Barriers for Better Care [0.03%]
肝病学人工智能挑战及未来展望：打破壁垒，优化治疗
Victoria E Kusztos,Douglas A Simonetto
Victoria E Kusztos
Artificial intelligence (AI) presents a compelling opportunity to revolutionize the practice of hepatology through a myriad of novel approaches ranging from predictive modeling to patient-specific clinical decision support systems. While AI...
Revisiting MASLD Nomenclature: Insights from the MENA Region and Its Clinical Relevance [0.03%]
重温MASLD命名：来自中东和北非地区的新见解及其临床意义
Khalid Alswat,Faisal Sanai,Waleed K Al-Hamoudi et al.
Khalid Alswat et al.
Long-Term Survival and Recurrence in HCC vs. Non-HCC Liver Transplant Recipients: A Two-Decade Longitudinal Analysis [0.03%]
肝移植受者的长期生存和复发与 hepatocellular carcinoma 患者对比：二十年纵向分析
Mahmoudreza Moein,Bridgette Nixon,Michael Leyderman et al.
Mahmoudreza Moein et al.
Background: We aim to compare the long-term survival outcomes of patients who have received liver transplants (LTs) as a result of primary hepatocellular carcinoma (HCC). ...
Response and Adverse Event Rates With Placebo in Compensated MASH-related Cirrhosis: A Meta-analysis [0.03%]
代用品在治疗代偿期MASH相关肝硬化中的反应和不良事件发生率：一项系统评价和 meta 分析
Marcio J M Amaral,Felipe S Moura,Luan C V Lima et al.
Marcio J M Amaral et al.
Dinesh Jothimani,Navin Kumar Marannan,Karan Jain et al.
Dinesh Jothimani et al.
Liver transplantation (LT) is the only cure for patients with end-stage liver disease. With an increase in the prevalence of obesity and associated metabolic risk factors cardiovascular disease, in particular coronary artery disease is incr...